CoChat

Nitroparacetamol exhibits anti‐inflammatory and anti‐nociceptive activity

Open access
Al‐Swayeh, O A, Futter, L E, Clifford, R H, Moore, P K · 2000 · British Journal of Pharmacology
Cited by 55

The DOI matches its Crossref record.

Abstract

Nitroparacetamol (NCX‐701) is a newly synthesized nitric oxide‐releasing derivative of paracetamol. Following i.p. administration, nitroparacetamol inhibits carrageenan‐induced hindpaw oedema formation (ED 50, 169.4 μmol kg−1) and mechanical hyperalgesia (ED 50, 156 μmol kg−1) in the rat. In contrast, the parent compound, paracetamol, exhibits no significant anti‐oedema activity in this model (ED 50>1986 μmol kg−1, i.p.) and is markedly less potent than nitroparacetamol as an inhibitor of carrageenan‐mediated hyperalgesia (ED 50, 411.6 μmol kg−1, i.p.). In a second model of nociception (inhibition of acetic acid induced abdominal constrictions in the mouse), nitroparacetamol administered orally (ED 50, 24.8 μmol kg−1), was again considerably more potent than paracetamol (ED 50, 506 μmol kg−1, p.o.). Thus, compared with paracetamol, nitroparacetamol not only exhibits augmented antinociceptive activity in both rat and mouse but, intriguingly, is also anti‐inflammatory over a similar dose range. British Journal of Pharmacology (2000) 130, 1453–1456; doi:10.1038/sj.bjp.0703509

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0703509

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 55

Metadata

Authors
Al‐Swayeh, O. A., Futter, L. E., Clifford, R. H., & Moore, P. K.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2000-08
Volume
130
Issue
7
Pages
1453-1456
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2035928774
Cited by
55
References
0
FWCI
2.83
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nitroparacetamol exhibits anti‐inflammatory and anti‐nociceptive activity. https://app.cochat.ai/papers/10.1038/sj.bjp.0703509
The paper
Al‐Swayeh, O. A., Futter, L. E., Clifford, R. H., & Moore, P. K. (2000). Nitroparacetamol exhibits anti‐inflammatory and anti‐nociceptive activity. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0703509

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.